Arbutus Biopharma Corp Property, Plant and Equipment, Gross
Arbutus Biopharma Corp (ABUS) had Property, Plant and Equipment, Gross of $245.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-23
- 2013-12-31: Property, Plant and Equipment, Gross 13.04M CAD.
- 2012-12-31: Property, Plant and Equipment, Gross 13.19M CAD; Property, Plant and Equipment, Gross as first filed 13.12M CAD.
- 2011-12-31: Property, Plant and Equipment, Gross 18.68M CAD.
- 2010-12-31: Property, Plant and Equipment, Gross 18.67M CAD.
CAD
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2013-12-31 | 13.04M CAD 10-K · filed 2014-03-28 | |
| 2012-12-31 | 13.19M CAD 10-K · filed 2014-03-28 | 13.12M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 18.68M CAD 20-F · filed 2013-03-27 | |
| 2010-12-31 | 18.67M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $245.00K 10-K · filed 2026-03-23 |
| 2024-12-31 | $16.30M 10-K · filed 2026-03-23 |
| 2023-12-31 | $16.57M 10-K · filed 2025-03-27 |
| 2022-12-31 | $15.87M 10-K · filed 2024-03-05 |
| 2021-12-31 | $15.36M 10-K · filed 2023-03-02 |
| 2020-12-31 | $14.55M 10-K · filed 2022-03-03 |
| 2019-12-31 | $14.32M 10-K · filed 2021-03-04 |
| 2018-12-31 | $17.04M 10-K · filed 2020-03-05 |
| 2018-09-30 | $16.81M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $16.58M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $25.08M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $24.85M 10-K · filed 2019-03-07 |
| 2017-09-30 | $24.75M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $24.28M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $22.52M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $17.68M 10-K · filed 2018-03-16 |
| 2016-09-30 | $14.55M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $14.12M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $13.17M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $12.91M 10-K · filed 2017-03-22 |
| 2015-09-30 | $12.24M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $12.47M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $11.93M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $12.96M 10-K · filed 2016-03-09 |
| 2014-09-30 | $13.09M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $13.59M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $13.37M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $13.04M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |